tradingkey.logo

Intuitive Surgical Inc

ISRG
504.620USD
-2.930-0.58%
Trading geöffnet ETKurse um 15 Minuten verzögert
178.89BMarktkapitalisierung
63.06KGV TTM

Intuitive Surgical Inc

504.620
-2.930-0.58%

mehr Informationen über Intuitive Surgical Inc Unternehmen

Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

Intuitive Surgical Inc Informationen

BörsenkürzelISRG
Name des UnternehmensIntuitive Surgical Inc
IPO-datumJun 13, 2000
CEORosa (David J)
Anzahl der mitarbeiter15638
WertpapierartOrdinary Share
GeschäftsjahresendeJun 13
Addresse1020 Kifer Road
StadtSUNNYVALE
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94086
Telefon14085232100
Websitehttps://www.intuitive.com/en-us/about-us/company
BörsenkürzelISRG
IPO-datumJun 13, 2000
CEORosa (David J)

Führungskräfte von Intuitive Surgical Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1000.00%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
228.75K
-5454.00%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
--
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+739.00%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+739.00%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
3.00K
-4731.00%
Dr. Monica P. Reed, M.D.
Dr. Monica P. Reed, M.D.
Independent Director
Independent Director
2.35K
+739.00%
Ms. Sreelakshmi Kolli
Ms. Sreelakshmi Kolli
Independent Director
Independent Director
979.00
+739.00%
Mr. Mark Preston Brosius
Mr. Mark Preston Brosius
Senior Vice President, Chief Manufacturing and Supply Chain Officer
Senior Vice President, Chief Manufacturing and Supply Chain Officer
852.00
-1076.00%
Mr. Lewis Chew
Mr. Lewis Chew
Independent Director
Independent Director
783.00
+739.00%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1000.00%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
228.75K
-5454.00%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
--
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+739.00%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+739.00%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
3.00K
-4731.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Instruments and accessories
1.52B
60.63%
Systems
590.40M
23.57%
Services
395.90M
15.80%
Nach RegionUSD
Name
Umsatz
Anteil
U.S.
1.72B
68.56%
Outside of United states
787.50M
31.44%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Instruments and accessories
1.52B
60.63%
Systems
590.40M
23.57%
Services
395.90M
15.80%

Aktionärsstatistik

Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.43%
BlackRock Institutional Trust Company, N.A.
5.33%
State Street Investment Management (US)
4.38%
T. Rowe Price Associates, Inc.
3.46%
Geode Capital Management, L.L.C.
2.33%
Andere
75.05%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.43%
BlackRock Institutional Trust Company, N.A.
5.33%
State Street Investment Management (US)
4.38%
T. Rowe Price Associates, Inc.
3.46%
Geode Capital Management, L.L.C.
2.33%
Andere
75.05%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
49.26%
Investment Advisor/Hedge Fund
27.06%
Hedge Fund
3.07%
Research Firm
2.90%
Pension Fund
2.47%
Bank and Trust
2.40%
Sovereign Wealth Fund
1.44%
Individual Investor
0.51%
Family Office
0.32%
Andere
10.58%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
3647
313.93M
88.55%
-8.96M
2025Q3
3649
310.67M
87.63%
-11.36M
2025Q2
3621
320.38M
89.37%
-5.49M
2025Q1
3598
321.67M
89.74%
-4.21M
2024Q4
3426
322.11M
90.31%
-1.17M
2024Q3
3255
319.27M
89.84%
-8.25M
2024Q2
3152
322.86M
91.02%
+572.17K
2024Q1
3116
317.58M
89.60%
-829.16K
2023Q4
3055
314.33M
89.27%
-2.70M
2023Q3
2961
312.82M
89.02%
-3.61M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
33.43M
9.43%
+258.72K
+0.78%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
18.90M
5.33%
-196.41K
-1.03%
Sep 30, 2025
State Street Investment Management (US)
15.54M
4.38%
-12.88K
-0.08%
Sep 30, 2025
T. Rowe Price Associates, Inc.
12.28M
3.46%
-605.75K
-4.70%
Sep 30, 2025
Geode Capital Management, L.L.C.
8.27M
2.33%
+84.99K
+1.04%
Sep 30, 2025
Invesco Capital Management (QQQ Trust)
7.95M
2.24%
+438.98K
+5.84%
Dec 31, 2025
Capital World Investors
7.73M
2.18%
+116.03K
+1.52%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.84M
1.36%
-3.59M
-42.62%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
4.73M
1.33%
+127.12K
+2.76%
Jun 30, 2025
AllianceBernstein L.P.
4.04M
1.14%
-153.40K
-3.66%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Thu, Oct 2
Aktualisiert: Thu, Oct 2
Name
Anteil
Langar Global HealthTech ETF
14.08%
iShares U.S. Medical Devices ETF
13.62%
Simplify Health Care ETF
6.65%
First Trust Nasdaq Lux Digi Health Solutions ETF
6.58%
Global X Robotics & Artificial Intelligence ETF
6.53%
Invesco AI and Next Gen Software ETF
5%
Goldman Sachs Future Health Care Equity ETF
4.73%
iShares US Select Equity Active ETF
4.67%
Neuberger Berman Disrupters ETF
4.34%
Fidelity Digital Health ETF
3.66%
Mehr Anzeigen
Langar Global HealthTech ETF
Anteil14.08%
iShares U.S. Medical Devices ETF
Anteil13.62%
Simplify Health Care ETF
Anteil6.65%
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil6.58%
Global X Robotics & Artificial Intelligence ETF
Anteil6.53%
Invesco AI and Next Gen Software ETF
Anteil5%
Goldman Sachs Future Health Care Equity ETF
Anteil4.73%
iShares US Select Equity Active ETF
Anteil4.67%
Neuberger Berman Disrupters ETF
Anteil4.34%
Fidelity Digital Health ETF
Anteil3.66%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Aug 05, 2021
Split
1→3
Datum
Ex-Dividendentag
Art
Verhältnis
Aug 05, 2021
Split
1→3
KeyAI